Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
522351
Reference Type
Journal Article
Title
Bovine model of marfan syndrome results from an amino acid change (c.3598G > A, p.E1200K) in a calcium-binding epidermal growth factor-like domain of fibrillin-1
Author(s)
Singleton, AC; Mitchell, AL; Byers, PH; Potter, KA; Pace, JM
Year
2005
Is Peer Reviewed?
Yes
Journal
Human Mutation
ISSN:
1059-7794
EISSN:
1098-1004
Volume
25
Issue
4
Page Numbers
348-352
Language
English
DOI
10.1002/humu.20152
Abstract
Marfan Syndrome (MFS) is an autosomal dominant disorder caused by mutations in the fibrillin-1 gene (FBN1). Several calves, all sired by a phenotypically normal bull, were found to exhibit the major clinical and pathological characteristics of human MFS (aortic dissection, joint laxity, tens dislocation), and were recognized as potential models of the human disease. In this study, Fbn1 cDNA from affected animals was sequenced and a heterozygous c.3598 G > A transition was detected in exon 29, which predicted the substitution of an evolutionarily conserved glutamic acid by lysine at position 1200 (p.E1200K). This residue is part of a calcium-binding epidermal growth factor-like (cbEGF-like) module, a domain that is frequently altered in human MFS. Analysis of genomic DNA from the original bull's sperm showed that less than 20 % of the sperm harbored the mutation, consistent with the presence of germline mosaicism. This study validates the use of these animals as models of human MFS. These cows will be valuable for investigations into the molecular pathogenesis of MFS, and may lead to better therapeutic testing and evaluation of human Marfan patients. (c) 2005 Wiley-Liss, Inc.
Keywords
Marfan syndrome; fibrillin-1; MFS; FBN 1; cbEGF-like domain; bovine; animal model; tgf-beta activation; osteogenesis imperfecta; friesian calves; fbn1; mutation; gene; pathogenesis; recurrence; mosaicism; sequence
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity